6.
Thygesen K, Alpert J, Jaffe A, Chaitman B, Bax J, Morrow D
. Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018; 138(20):e618-e651.
DOI: 10.1161/CIR.0000000000000617.
View
7.
Byrne R, Rossello X, Coughlan J, Barbato E, Berry C, Chieffo A
. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023; 44(38):3720-3826.
DOI: 10.1093/eurheartj/ehad191.
View
8.
Lawton J, Tamis-Holland J, Bangalore S, Bates E, Beckie T, Bischoff J
. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021; 145(3):e18-e114.
DOI: 10.1161/CIR.0000000000001038.
View
9.
Ozaki Y, Hara H, Onuma Y, Katagiri Y, Amano T, Kobayashi Y
. CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022. Cardiovasc Interv Ther. 2022; 37(1):1-34.
PMC: 8789715.
DOI: 10.1007/s12928-021-00829-9.
View
10.
Lee J, Choi K, Song Y, Lee J, Lee S, Lee S
. Intravascular Imaging-Guided or Angiography-Guided Complex PCI. N Engl J Med. 2023; 388(18):1668-1679.
DOI: 10.1056/NEJMoa2216607.
View
11.
Urban P, Mehran R, Colleran R, Angiolillo D, Byrne R, Capodanno D
. Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk. Eur Heart J. 2019; 40(31):2632-2653.
PMC: 6736433.
DOI: 10.1093/eurheartj/ehz372.
View
12.
Bozkurt B, Coats A, Tsutsui H, Abdelhamid C, Adamopoulos S, Albert N
. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal.... Eur J Heart Fail. 2021; 23(3):352-380.
DOI: 10.1002/ejhf.2115.
View
13.
Badheka A, Patel N, Grover P, Singh V, Patel N, Arora S
. Impact of annual operator and institutional volume on percutaneous coronary intervention outcomes: a 5-year United States experience (2005-2009). Circulation. 2014; 130(16):1392-406.
DOI: 10.1161/CIRCULATIONAHA.114.009281.
View
14.
Choi K, Lee S, Song Y, Park T, Lee J, Yang J
. Prognostic Impact of Operator Experience and IVUS Guidance on Long-Term Clinical Outcomes After Complex PCI. JACC Cardiovasc Interv. 2023; 16(14):1746-1758.
DOI: 10.1016/j.jcin.2023.04.022.
View
15.
Hochman J, Anthopolos R, Reynolds H, Bangalore S, Xu Y, OBrien S
. Survival After Invasive or Conservative Management of Stable Coronary Disease. Circulation. 2022; 147(1):8-19.
PMC: 9797439.
DOI: 10.1161/CIRCULATIONAHA.122.062714.
View
16.
Perera D, Clayton T, OKane P, Greenwood J, Weerackody R, Ryan M
. Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction. N Engl J Med. 2022; 387(15):1351-1360.
DOI: 10.1056/NEJMoa2206606.
View
17.
Dargie H
. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet. 2001; 357(9266):1385-90.
DOI: 10.1016/s0140-6736(00)04560-8.
View
18.
Jong P, Yusuf S, Rousseau M, Ahn S, Bangdiwala S
. Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study. Lancet. 2003; 361(9372):1843-8.
DOI: 10.1016/S0140-6736(03)13501-5.
View
19.
Pitt B, Zannad F, Remme W, Cody R, CASTAIGNE A, Perez A
. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999; 341(10):709-17.
DOI: 10.1056/NEJM199909023411001.
View
20.
McMurray J, Solomon S, Inzucchi S, Kober L, Kosiborod M, Martinez F
. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2019; 381(21):1995-2008.
DOI: 10.1056/NEJMoa1911303.
View